BioStrategy Advisors is a strategic business consulting firm servicing small and medium-sized Biotech companies in the Massachusetts area. Specializing in biotech start-up corporate strategy, early commercial planning for assets in early-stage clinical development and commercial product launch planning for later-stage specialty therapeutics and/or orphan drugs/rare diseases. Extensive experience in developing the strategy for geographic expansion and determining go-to-market models for a solid global footprint. Assistance on finding and selecting partners for licensing, full-service distribution or 3PLs in the different regions (US, EU, Canada, Asia, LATAM). Initial alliance management. Advise on structuring terms and economics of licensing deals.
Early Commercial Considerations
Strategic advice for early stage, pre-clinical and clinical stage Biotech companies on matters related to starting-up the business (ie. overall corporate strategy, investors presentations, IP protection, development, global regulatory strategy and commercialization timelines).
Global Footprint Design & Go-To-Market Strategy
Customized effective decision-making tools to help Biotech companies build a solid geographical footprint and develop the best strategy for the successful global launch of specialized drugs or rare disease/orphan drugs. Advice on country prioritization, go-to-market models, launch cadence, pricing and market access considerations, etc.
Local Structure and/or Strategic Alliances
Establishment of a direct presence (subsidiary set-up, local structure design) or a solid partnership if not going it alone. Identification and evaluation of potential partners (ie. licensees, full-service distributors, 3PLs). Development of shop-around decks and presentations. Structuring of deal terms and economics. Initial alliance management.